| Treatment of cutaneous T-cell lymphoma: focus on vorinostat. | |
| | |
MedLine Citation:
|
PMID: 18793938 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Warren R. Heymann, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology. |
| | |
Authors:
|
Warren R Heymann |
Related Documents
:
|
18158928 - The human genome: mutating from science fiction to reality. 16735878 - Recertification: history of abos efforts. 19790008 - American academy of dermatology--summer meeting. 29 july-2 august 2009, boston, ma, usa. 19097268 - The world federation of societies of anaesthesiologists and pediatric anesthesia. 22348308 - Generalizing complexity: a fruitful partnership of functional genomics and systems biol... 20376388 - Chemistry and biology of siderophores. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of the American Academy of Dermatology Volume: 59 ISSN: 1097-6787 ISO Abbreviation: J. Am. Acad. Dermatol. Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-09-16 Completed Date: 2008-09-30 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 7907132 Medline TA: J Am Acad Dermatol Country: United States |
Other Details:
|
Languages: eng Pagination: 696-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
adverse effects,
therapeutic use Fatigue / chemically induced Gastrointestinal Diseases / chemically induced Histone Deacetylase Inhibitors* Humans Hydroxamic Acids / adverse effects, therapeutic use* Lymphoma, T-Cell, Cutaneous / drug therapy*, pathology Neoplasm Staging Pulmonary Embolism / chemically induced |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/Histone Deacetylase Inhibitors; 0/Hydroxamic Acids; 149647-78-9/vorinostat |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Basal cell carcinoma with a sarcomatous component (carcinosarcoma): a series of 5 cases and a review...
Next Document: Therapeutic interventions for vitiligo.